Castle Biosciences Stock Target Price and Analyst Consensus
| CSTL Stock | USD 23.26 0.95 3.92% |
The current analyst and expert consensus on Castle Biosciences is Strong Buy, with 8 strong buy opinions. The current projected Castle Biosciences target price consensus is 33.00 with 9 analyst opinions. The most common way Castle Biosciences analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Castle Biosciences executives and customers to further validate their buy or sell advice. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Castle Biosciences. We strongly encourage you to use your own analysis of Castle Biosciences to validate this buy or sell advice. Castle Biosciences buy-or-sell recommendation module provides average expert sentiment on the projected Castle Biosciences target price to derive its highest and lowest estimates based on its projected price volatility. Check out Macroaxis Advice on Castle Biosciences to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more information on how to buy Castle Stock please use our How to buy in Castle Stock guide.
Lowest Forecast 30.03 | Highest Forecast 36.63 | Target Price 33 |
Castle |
It's important to approach Castle Biosciences' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Castle Biosciences price targets
Castle Biosciences' stock target price is an estimate of its future price, usually made by analysts. Using Castle Biosciences' target price to determine if it is a suitable investment can be done through the following steps:- Look at Castle Biosciences' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Castle Biosciences' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Castle Biosciences Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Castle Biosciences is a key component of Castle Biosciences valuation and have some predictive power on the future returns of a Castle Biosciences.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Castle Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Business Services Invested few shares | |
 | Hedge Favorites Invested over 70 shares | |
 | Dividend Beast Invested over 70 shares | |
 | Adviser Favorites Invested few shares | |
 | ESG Investing Invested few shares | |
Check out Macroaxis Advice on Castle Biosciences to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more information on how to buy Castle Stock please use our How to buy in Castle Stock guide.You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Complementary Tools for Castle Stock analysis
When running Castle Biosciences' price analysis, check to measure Castle Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Castle Biosciences is operating at the current time. Most of Castle Biosciences' value examination focuses on studying past and present price action to predict the probability of Castle Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Castle Biosciences' price. Additionally, you may evaluate how the addition of Castle Biosciences to your portfolios can decrease your overall portfolio volatility.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |
The data published in Castle Biosciences' official financial statements usually reflect Castle Biosciences' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Castle Biosciences. For example, before you start analyzing numbers published by Castle accountants, it's critical to develop an understanding of what Castle Biosciences' liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Castle Biosciences' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Castle Biosciences' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Castle Biosciences' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Castle Biosciences. Please utilize our Beneish M Score to check the likelihood of Castle Biosciences' management manipulating its earnings.